Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	18.88	64.26	54.06
Graham Fair Price	-41.00	25.14	42.61
PEG	-632.20	-2.30	-0.31
Price/Book	20.80	1.87	1.55
Price/Cash Flow	215.05	180.91	57.42
Prices/Earnings	236.22	147.56	43.89
Price/Sales	23.74	7.55	6.10
Price/FCF	215.05	180.91	57.42
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.05	0.36	0.35
Operating Margin	-1.16	0.09	0.10
ROA	-63.74	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-64.07
ROIC	< 0.005	< 0.005	-17.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	161.45
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	8.53	-0.05	-99.43
EPS QOQ	1.40	-0.64	-54.08
FCF QOQ	0.06	-0.62	968.65
Revenue QOQ	-0.03	-0.04	-49.19
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	109.74	119.36	8.77
Days Sales Outstanding (DSO)	51.58	48.15	-6.63
Inventory Turnover	0.82	0.75	-8.06
Debt/Capitalization	0.50	0.50	0.14
Quick Ratio	1.13	1.04	-8.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	95.69	94.19	-1.56
Cash	8.66	7.01	-19.06
Capex	-0.46	-0.28	39.24
Free Cash Flow	2.58	0.97	-62.26
Revenue	24.26	23.31	-3.91
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.55	2.62	2.52
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.46	21.67	5.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating